Abstract

Human calcium-sensing receptor (CaSR) is a G-protein coupled receptor (GPCR) that maintains extracellular Ca2+ homeostasis through the regulation of parathyroid hormone secretion. It functions as a disulfide-tethered homodimer composed of three main domains, the Venus Flytrap module, cysteine-rich domain, and seven-helix transmembrane region. Here we present the crystal structures of the entire extracellular domain of CaSR in the resting and active conformations. We provide direct evidence that L-amino acids are agonists of the receptor. In the active structure, L-Trp occupies the orthosteric agonist-binding site at the interdomain cleft, and is primarily responsible for inducing extracellular domain closure to initiate receptor activation. Our structures reveal multiple binding sites for Ca2+ and PO43- ions. Both ions are crucial for structural integrity of the receptor. While Ca2+ ions stabilize the active state, PO43- ions reinforce the inactive conformation. The activation mechanism of CaSR involves the formation of a novel dimer interface between subunits.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Yong Geng

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Lidia Mosyak

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Igor Kurinov

    Department of Chemistry and Chemical Biology, Cornell University, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Hao Zuo

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Emmanuel Sturchler

    Department of Molecular Therapeutics, The Scripps Translational Science Institute, Jupiter, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Tat Cheung Cheng

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Prakash Subramanyam

    Department of Physiology and Cellular Biophysics, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Alice P Brown

    School of Life and Environmental Sciences, University of Sydney, New South Wales, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Sarah C Brennan

    School of Life and Environmental Sciences, University of Sydney, New South Wales, Australia
    Competing interests
    The authors declare that no competing interests exist.
  10. Hee-chang Mun

    School of Life and Environmental Sciences, University of Sydney, New South Wales, Australia
    Competing interests
    The authors declare that no competing interests exist.
  11. Martin Bush

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Yan Chen

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Trang X Nguyen

    Department of Psychiatry, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Baohua Cao

    Department of Pharmacology, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Donald D Chang

    Department of Physiology and Cellular Biophysics, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Matthias Quick

    Department of Psychiatry, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Arthur D Conigrave

    School of Life and Environmental Sciences, University of Sydney, New South Wales, Australia
    Competing interests
    The authors declare that no competing interests exist.
  18. Henry M Colecraft

    Department of Physiology and Cellular Biophysics, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Patricia McDonald

    Department of Molecular Therapeutics, The Scripps Translational Science Institute, Jupiter, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. Qing R Fan

    Department of Pharmacology, Columbia University, New York, United States
    For correspondence
    qf13@cumc.columbia.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9330-0963

Funding

National Institute of General Medical Sciences (R01GM112973)

  • Qing R Fan

American Heart Association (15GRNT25420002)

  • Qing R Fan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Ehud Y Isacoff, University of California, Berkeley, United States

Version history

  1. Received: December 9, 2015
  2. Accepted: July 18, 2016
  3. Accepted Manuscript published: July 19, 2016 (version 1)
  4. Version of Record published: August 8, 2016 (version 2)

Copyright

© 2016, Geng et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,360
    Page views
  • 1,556
    Downloads
  • 176
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yong Geng
  2. Lidia Mosyak
  3. Igor Kurinov
  4. Hao Zuo
  5. Emmanuel Sturchler
  6. Tat Cheung Cheng
  7. Prakash Subramanyam
  8. Alice P Brown
  9. Sarah C Brennan
  10. Hee-chang Mun
  11. Martin Bush
  12. Yan Chen
  13. Trang X Nguyen
  14. Baohua Cao
  15. Donald D Chang
  16. Matthias Quick
  17. Arthur D Conigrave
  18. Henry M Colecraft
  19. Patricia McDonald
  20. Qing R Fan
(2016)
Structural mechanism of ligand activation in human calcium-sensing receptor
eLife 5:e13662.
https://doi.org/10.7554/eLife.13662

Share this article

https://doi.org/10.7554/eLife.13662

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Daniyal Tariq, Nicole Maurici ... Brian R Crane
    Research Article

    Circadian clocks are composed of transcription-translation negative feedback loops that pace rhythms of gene expression to the diurnal cycle. In the filamentous fungus Neurospora crassa, the proteins Frequency (FRQ), the FRQ-interacting RNA helicase (FRH), and Casein-Kinase I (CK1) form the FFC complex that represses expression of genes activated by the white-collar complex (WCC). FRQ orchestrates key molecular interactions of the clock despite containing little predicted tertiary structure. Spin labeling and pulse-dipolar electron spin resonance spectroscopy provide domain-specific structural insights into the 989-residue intrinsically disordered FRQ and the FFC. FRQ contains a compact core that associates and organizes FRH and CK1 to coordinate their roles in WCC repression. FRQ phosphorylation increases conformational flexibility and alters oligomeric state, but the changes in structure and dynamics are non-uniform. Full-length FRQ undergoes liquid–liquid phase separation (LLPS) to sequester FRH and CK1 and influence CK1 enzymatic activity. Although FRQ phosphorylation favors LLPS, LLPS feeds back to reduce FRQ phosphorylation by CK1 at higher temperatures. Live imaging of Neurospora hyphae reveals FRQ foci characteristic of condensates near the nuclear periphery. Analogous clock repressor proteins in higher organisms share little position-specific sequence identity with FRQ; yet, they contain amino acid compositions that promote LLPS. Hence, condensate formation may be a conserved feature of eukaryotic clocks.

    1. Structural Biology and Molecular Biophysics
    Raphael Trenker, Devan Diwanji ... Natalia Jura
    Research Article

    Human Epidermal growth factor Receptor 4 (HER4 or ERBB4) carries out essential functions in the development and maintenance of the cardiovascular and nervous systems. HER4 activation is regulated by a diverse group of extracellular ligands including the neuregulin (NRG) family and betacellulin (BTC), which promote HER4 homodimerization or heterodimerization with other HER receptors. Important cardiovascular functions of HER4 are exerted via heterodimerization with its close homolog and orphan receptor, HER2. To date structural insights into ligand-mediated HER4 activation have been limited to crystallographic studies of HER4 ectodomain homodimers in complex with NRG1β. Here, we report cryo-EM structures of near full-length HER2/HER4 heterodimers and full-length HER4 homodimers bound to NRG1β and BTC. We show that the structures of the heterodimers bound to either ligand are nearly identical and that in both cases the HER2/HER4 heterodimer interface is less dynamic than those observed in structures of HER2/EGFR and HER2/HER3 heterodimers. In contrast, structures of full-length HER4 homodimers bound to NRG1β and BTC display more large-scale dynamics mirroring states previously reported for EGFR homodimers. Our structures also reveal the presence of multiple glycan modifications within HER4 ectodomains, modeled for the first time in HER receptors, that distinctively contribute to the stabilization of HER4 homodimer interfaces over those of HER2/HER4 heterodimers.